Loading the security overview…
Where the tokens are
What Halozyme Therapeutics has filed with the US Securities and Exchange Commission: annual and quarterly reports, current reports of material events, and the forms insiders file when they trade. Each links to the filing’s page on SEC.gov.
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Sep 30, 2026 | 8-K | Current report | On SEC.gov |
| Sep 22, 2026 | 8-K | Current report | On SEC.gov |
| Sep 18, 2026 | 8-K | Current report | On SEC.gov |
| Sep 16, 2026 | 8-K | Current report | On SEC.gov |
| Aug 18, 2026 | 8-K | Current report | On SEC.gov |
| Aug 6, 2026 | 10-Q | Quarterly report | On SEC.gov |
| Aug 6, 2026 | 8-K | Current report | On SEC.gov |
| Jul 2, 2026 | 8-K | Current report | On SEC.gov |
| May 11, 2026 | 10-Q | Quarterly report | On SEC.gov |
| May 11, 2026 | 8-K | Current report | On SEC.gov |
| May 7, 2026 | 8-K | Current report | On SEC.gov |
| Apr 30, 2026 | 8-K | Current report | On SEC.gov |
| Apr 24, 2026 | 8-K | Current report | On SEC.gov |
| Mar 12, 2026 | 8-K | Current report | On SEC.gov |
| Feb 17, 2026 | 10-K | Annual report | On SEC.gov |
| Feb 17, 2026 | 8-K | Current report | On SEC.gov |
| Jan 28, 2026 | 8-K | Current report | On SEC.gov |
| Dec 9, 2025 | 8-K | Current report | On SEC.gov |
| Dec 8, 2025 | 8-K | Current report | On SEC.gov |
| Nov 24, 2025 | 8-K | Current report | On SEC.gov |
| Nov 12, 2025 | 8-K | Current report | On SEC.gov |
| Nov 7, 2025 | 8-K | Current report | On SEC.gov |
| Nov 5, 2025 | 8-K | Current report | On SEC.gov |
| Nov 3, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Nov 3, 2025 | 8-K | Current report | On SEC.gov |
| Oct 14, 2025 | 8-K | Current report | On SEC.gov |
| Oct 6, 2025 | 8-K | Current report | On SEC.gov |
| Oct 3, 2025 | 8-K | Current report | On SEC.gov |
| Oct 1, 2025 | 8-K | Current report | On SEC.gov |
| Aug 5, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Aug 5, 2025 | 8-K | Current report | On SEC.gov |
| May 6, 2025 | 10-Q | Quarterly report | On SEC.gov |
| May 6, 2025 | 8-K | Current report | On SEC.gov |
| May 2, 2025 | 8-K | Current report | On SEC.gov |
| Mar 21, 2025 | 8-K | Current report | On SEC.gov |
| Feb 18, 2025 | 10-K | Annual report | On SEC.gov |
| Feb 18, 2025 | 8-K | Current report | On SEC.gov |
| Feb 13, 2025 | 8-K | Current report | On SEC.gov |
| Jan 8, 2025 | 8-K | Current report | On SEC.gov |
| Oct 31, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Oct 31, 2024 | 8-K | Current report | On SEC.gov |
| Aug 6, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Aug 6, 2024 | 8-K | Current report | On SEC.gov |
| May 7, 2024 | 10-Q | Quarterly report | On SEC.gov |
| May 7, 2024 | 8-K | Current report | On SEC.gov |
| Apr 26, 2024 | 8-K | Current report | On SEC.gov |
| Feb 20, 2024 | 10-K | Annual report | On SEC.gov |
| Feb 20, 2024 | 8-K | Current report | On SEC.gov |
| Jan 17, 2024 | 8-K | Current report | On SEC.gov |
| Nov 6, 2023 | 10-Q | Quarterly report | On SEC.gov |
| Nov 6, 2023 | 8-K | Current report | On SEC.gov |
| Sep 7, 2023 | 8-K | Current report | On SEC.gov |
| Aug 8, 2023 | 10-Q | Quarterly report | On SEC.gov |
| Aug 8, 2023 | 8-K | Current report | On SEC.gov |
| May 9, 2023 | 10-Q | Quarterly report | On SEC.gov |
| May 9, 2023 | 8-K | Current report | On SEC.gov |
| May 8, 2023 | 8-K | Current report | On SEC.gov |
| Mar 16, 2023 | 8-K | Current report | On SEC.gov |
| Mar 13, 2023 | 8-K | Current report | On SEC.gov |
| Feb 23, 2023 | 8-K | Current report | On SEC.gov |
Figures describe Halozyme Therapeutics shares, not any token. As of Sep 30, 2026, from EDGAR, via Massive. Token issuers file nothing here about the company; their own disclosures are on their issuer pages.